MCKENNA MORAN: Open Payments
NPI 1699548388 · SCRANTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 27 payments from 7 companies in 2025. Trend: 2023 $22 · 2024 $728 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $168 |
| Dexcom, Inc. | 2 | $138 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $136 |
| Sequel Med Tech, LLC | 4 | $85 |
| Tandem Diabetes Care, Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $44 |
| Abbott Laboratories | 1 | $25 |
Products named: MOUNJARO, Dexcom G6 Transmitter, JARDIANCE, TWIIST, t:slim X2 Insulin Pump with Control-IQ, Ozempic, FREESTYLE LIBRE 3.
Industry payments across PA — which companies pay providers there.
